ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
2.370
+0.130 (5.80%)
At close: Aug 13, 2025, 4:00 PM
2.380
+0.010 (0.42%)
Pre-market: Aug 14, 2025, 8:59 AM EDT
ProKidney Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for ProKidney stock ranges from a low of $1.00 to a high of $9.00. The average analyst price target of $6.25 forecasts a 163.71% increase in the stock price over the next year.
Price Target: $6.25 (+163.71%)
Analyst Consensus: Buy
* Price targets were last updated on Jul 15, 2025.
Analyst Ratings
The average analyst rating for ProKidney stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 3 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $4 → $8 | Strong Buy | Maintains | $4 → $8 | +237.55% | Jul 15, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $6 → $7 | Strong Buy | Maintains | $6 → $7 | +195.36% | Jul 14, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $6 → $9 | Strong Buy | Maintains | $6 → $9 | +279.75% | Jul 9, 2025 |
| B of A Securities | B of A Securities | Hold → Sell Downgrades $3 → $1 | Hold → Sell | Downgrades | $3 → $1 | -57.81% | Jun 30, 2025 |
| JP Morgan | JP Morgan | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 30, 2024 |
Financial Forecast
Revenue This Year
156.40K
from 76.00K
Increased by 105.79%
Revenue Next Year
n/a
from 156.40K
EPS This Year
-0.56
from -0.62
EPS Next Year
-0.52
from -0.56
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 241,500 | n/a | n/a | ||
| Avg | 156,397 | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 217.8% | - | - | ||
| Avg | 105.8% | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.47 | -0.19 | -0.18 | ||
| Avg | -0.56 | -0.52 | -0.58 | ||
| Low | -0.67 | -0.77 | -0.80 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.